beta

You're viewing our new website - find out more

Publication - Consultation Paper

Clinical Trial Access quality performance indicator: consultation

Published: 3 Jul 2017
Part of:
Health and social care
ISBN:
9781788510912

Consultation on the effectiveness of the Clinical Trial Access quality performance indicator (QPI) as part of the National Cancer QPIs.

20 page PDF

492.4kB

20 page PDF

492.4kB

Contents
Clinical Trial Access quality performance indicator: consultation
6. Quality Performance Indicator for Clinical Trial Access

20 page PDF

492.4kB

6. Quality Performance Indicator for Clinical Trial Access

QPI Title: All patients should be considered for participation in available clinical trials, wherever eligible.
Description: Proportion of patients with [insert tumour type] cancer who are consented* for a clinical trial.
Rationale and Evidence: Clinical trials are necessary to demonstrate the efficacy of new therapies and other interventions. Furthermore evidence suggests improved patient outcomes from participation in clinical trials [3] . Clinicians are therefore encouraged to enter patients into well-designed trials and to collect longer-term follow-up data. High accrual activity into clinical trials is used as a goal of an exemplary clinical research site.
Specifications:
Numerator:
Number of patients with [insert tumour type] cancer consented for a clinical trial.
Denominator:
All patients with [insert tumour type] cancer.
Exclusions:
  • No exclusions.
Target: 15% The target level has been agreed based on National Cancer Research Institute ( NCRI) data (see appendix 5).

*consented is defined as patients who have given consent to participate in a clinical trial subject to study specific screening for eligibility.

Revision(s):

Updated to measure patients consented rather than enrolled

Combined target of 15% (for all types of trials)


Contact

Email: Chris Booth, chris.booth@gov.scot

Phone: 0300 244 4000 – Central Enquiry Unit

The Scottish Government
St Andrew's House
Regent Road
Edinburgh
EH1 3DG